The effectiveness evaluation of polyethylene glycol electrolyte solution in bowel preparation in divided doses of two days for elderly constipation patients
-
摘要:
目的 比较分析老年便秘患者结肠镜检查前1 d与检查当天分次服用复方聚乙二醇电解质散与检查前6 h一次性服用相同剂量的复方聚乙二醇电解质散的肠道准备效果及患者对不同方案的耐受情况。 方法 根据罗马Ⅳ便秘诊断标准,选取年龄在60~85岁的拟行无痛结肠镜检查的轻中度便秘患者150例,随机抽签分为A、B、C 3组,每组各50例。A组于检查前1 d下午15:00服用复方聚乙二醇电解质散1 L,检查前6 h再服用2 L;B组于检查前6 h服用复方聚乙二醇电解质散3 L;C组于检查前1 d晚上20:00服用复方聚乙二醇电解质散1 L,检查前6 h再服用2 L,3组患者的结肠镜检查时间点及检查前1 d饮食均相同。采用波士顿肠道准备量表(Boston bowel preparation scale,BBPS)评估肠道清洁度,记录结肠镜检查进镜时间,二者均由同一内镜医师单盲记录,患者对不同肠道准备方案的耐受性和不良反应采用问卷调查的方式获得。 结果 所有患者均较好地完成肠道准备及结肠镜检查,3组结肠镜进镜时间分别为(4.34±1.29)min、(4.59±1.32)min、(4.45±1.50)min, BBPS评分后肠道准备质量优良率分别为95.7%、93.9%、95.9%,差异无统计学意义(均P>0.05);A组肠道准备耐受率为85.11%,C组为79.59%,均优于B组的62.22%;A组不良反应发生比例最低,为31.91%,C组为57.14%,B组最高,为93.88%,差异均具有统计学意义(均P < 0.05)。 结论 隔天分次口服复方聚乙二醇电解质散与常规结肠镜检查前6 h一次性服用相同剂量药物肠道准备效果无差别,但隔天服用对老年便秘患者具有更好的耐受性,不良反应更少,尤其是提前1 d下午服用,对睡眠影响少,值得临床推广。 -
关键词:
- 老年便秘 /
- 复方聚乙二醇电解质散 /
- 隔天分次口服 /
- 肠道准备
Abstract:Objective To compare and analyze the bowel preparation effect and patient tolerance to different regimens of elderly constipation patients taking compound polyethylene glycol electrolyte powder in several doses 1 day before colonoscopy and on the same day as taking the same dose once 6 hours before colonoscopy. Methods According to the diagnostic criteria of Roman Ⅳ constipation, 150 mild to moderate constipation patients aged 60~85 years who were to undergo painless colonoscopy were selected and randomly divided into A, B and C groups, with 50 people in each group. Group A took 1 L of compound PEGYlated electrolyte powder at 15:00 1 day before the examination, and 2 L 6 hours before the examination. Group B received 3 L of compound PEGYlated electrolyte powder 6 hours before the examination. In group C, 1 L of compound PEGYlated electrolyte powder was taken at 20:00 1 day before the examination, and 2 L was taken 6 hours before the examination. The colonoscopy time point and diet of patients in the 3 groups were the same. Bowel cleanliness was assessed using the Boston Bowel Preparation Scale (BBPS), and scope-forward time was recorded. Both were recorded singly and blindly by the same endoscope physician. Patients' tolerance to different bowel preparation plans and adverse reactions were obtained through questionnaire survey. Results All patients completed bowel preparation and colonoscopy well. The average scope-forward time of the 3 groups were (4.34±1.29) min, (4.59±1.32) min, (4.45±1.50) min, and the good and good rates of bowel preparation quality after BBPS score were 95.7%, 93.9%, and 95.9%, respectively, with no statistically significant difference (all P>0.05). The bowel preparation tolerance rate in group A and Group C were 85.11% and 79.59%, both of which were better than 62.22% in group B. The incidence of adverse reactions in group A was the lowest (31.91%, 57.14% and 93.88%), and the results were statistically significant (all P < 0.05). Conclusion There is no difference in the effect of bowel preparation between the next day by several times of oral complex polyethylene glycol electrolyte powder and conventional colonoscopy one-time 6 hours before taking the same dose drugs, but the next day taking has better tolerance in patients with senile constipation, less adverse reaction, especially in the afternoon to take 1 day in advance and influence to sleep less, worth clinical promotion. -
表 1 3组结肠镜检查患者一般资料比较(x ±s)
组别 例数 年龄(岁) 性别(男/女,例) A组 47 73.60±5.00 20/27 B组 49 72.67±4.88 22/27 C组 49 71.63±4.46 21/28 统计量 2.026a 0.064b P值 0.136 0.968 注:a为F值,b为χ2值。 表 2 3组结肠镜检查患者肠道清洁情况比较(x ±s, 分)
组别 例数 右侧结肠BBPS评分 中段结肠BBPS评分 左侧结肠BBPS评分 BBPS评分总分 A组 47 2.07±0.80 1.60±0.83 2.11±0.90 6.72±1.10 B组 49 1.98±0.80 2.07±0.82 2.05±0.82 7.00±1.24 C组 49 2.03±0.84 2.05±0.79 1.89±0.76 6.71±1.27 F值 0.081 2.191 0.819 1.604 P值 0.922 0.116 0.443 0.163 表 3 3组结肠镜检查患者肠道准备耐受情况比较[例(%)]
分组 例数 胃肠道耐受情况 耐受率(%) 1分 2分 3分 4分 A组 47 1(2.13) 6(12.77) 10(21.28) 30(63.83) 85.11(40/47)b B组 49 6(12.24) 13(26.53) 16(32.65) 14(28.57) 61.22(30/49) C组 49 3(6.12) 7(14.29) 14(28.57) 25(51.02) 79.59(39/49)b 统计量 14.310a 8.106c P值 0.026 0.017 注:a为Z值,c为χ2值。与B组比较,bP < 0.05。 表 4 3组结肠镜检查患者肠道准备过程中不良反应发生情况比较[例(%)]
组别 例数 不良反应 影响睡眠 低血糖 腹痛 恶心 呕吐 A组 47 2(4.26)a 3(6.38)a 7(14.89)a 1(2.13)a 2(4.26) B组 49 11(22.45) 10(20.41) 17(34.69) 8(16.33) C组 49 5(10.20)a 3(6.12)a 7(14.29)a 3(6.12)a 10(20.41) χ2值 7.636 6.626 7.811 6.823 5.723 P值 0.022 0.036 0.020 0.033 0.017 注:与B组比较,aP < 0.05。 -
[1] 肖静, 于子涵. 无痛胃肠镜在诊疗消化道疾病中的安全性及应用价值[J]. 中国疗养医学, 2017, 26(1): 56-58. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGLX201701025.htm [2] MAIDA M, MORREALE G, SINAGRA E, et al. Quality measures improving endoscopic screening of colorectal cancer: a review of the literature [J]. Expert Rev Anticancer Ther, 2019, 19(3): 223-235. doi: 10.1080/14737140.2019.1565999 [3] GUO R, WANG Y J, LIU M, et al. The Effect of Quality of Segmental Bowel Preparation on Adenoma Detection Rate [J]. BMC Gastroenterol, 2019, 19(1): 119. doi: 10.1186/s12876-019-1019-8 [4] 占俊, 汤进芝, 汪文生, 等. 不同剂型聚乙二醇电解质在结肠镜检查前肠道准备中的应用比较[J]. 中华全科医学, 2020, 18(8): 1283-1286. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202008011.htm [5] 张智, 葛兆霞, 邓小岚. 老年患者结肠镜检查前不同肠道准备方法的效果对比[J]. 中华现代护理杂志, 2017, 23(14): 1829-1832. doi: 10.3760/cma.j.issn.1674-2907.2017.14.001 [6] HORTON N, GARBER A, HASSON H, et al. Impact of single-vs. split-dose low-volume bowel preparations on bowel movement kinetics, patient inconvenience, and polyp detection: a prospective trial[J]. Am J Gastroenterol, 2016, 111(9): 1330-1337. doi: 10.1038/ajg.2016.273 [7] RUSSO M, STRISCIUGLIO C, SCARPATO E, et al. Functional chronic constipation: rome Ⅲ criteria versus rome iv critiera [J]. J Neurogastroenterol Motil, 2019, 25(1): 123-128. doi: 10.5056/jnm18035 [8] VAZQUEZ ROQUE M, BOURAS E P. Epidemiology and management of chronic constipation in elderly patients [J]. Clin Interv Aging, 2015, 10: 919-930. http://www.dovepress.com/getfile.php?fileID=25284 [9] 中华医学会老年医学分会, 中华老年医学杂志编辑委员会. 老年人慢性便秘的评估与处理专家共识[J]. 中华老年医学杂志, 2017, 36(4): 371-381. doi: 10.3760/cma.j.issn.0254-9026.2017.04.007 [10] SULZ M C, KRÖGER A, PRAKASH M, et al. Meta-analysis of the effect of bowel preparation on adenoma detection: early adenomas affected stronger than advanced adenomas[J]. PLoS One, 2016, 11(6): e0154149. doi: 10.1371/journal.pone.0154149 [11] 中华医学会消化内镜学分会. 中国消化内镜诊疗相关肠道准备指南(草案)[J]. 胃肠病学, 2014, 19(6): 354-356. doi: 10.3969/j.issn.1008-7125.2014.06.009 [12] ALVAREZ-GONZALEZ M A, PANTALEON M A, FLORES-LE ROUX J A, et al. Randomized clinical trial: a normocaloric low-fiber diet the day before colonoscopy is the most effective approach to bowel preparation in colorectal cancer screening colonoscopy [J]. Dis Colon Rectum, 2019, 62(4): 491-497. doi: 10.1097/DCR.0000000000001305 [13] WALTER J, FRANCIS G, MATRO R, et al. The impact of diet liberalization on bowel preparation for colonoscopy [J]. Endosc Int Open, 2017, 5(4): 253-260. doi: 10.1055/s-0043-101694 [14] KANG M K, JANG B L, PARK J S, et al. Efficacy of ramosetron in combination with polyethylene glycol of preparing for a colonoscopy [J]. Yeungnam Univ J Med, 2019, 36(2): 99-104. doi: 10.12701/yujm.2019.00080 [15] LÓPEZ S, VARGAS C, LÓPEZ C. Effectiveness and tolerability of low volume bowel cleansing polyethylene glycol solution for colonoscopy [J]. Rev Med Chil, 2019, 147(8): 977-982. doi: 10.4067/S0034-98872019000800977 [16] 樊波. 聚乙二醇电解质口服溶液在老年患者结肠镜检查前肠道准备中的应用[J]. 中国药物与临床, 2019, 19(16): 2795-2796. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201916049.htm [17] ZHANG S, LI M, ZHAO Y, et al. 3-L split-dose is superior to 2-L polyethylene glycol in bowel cleansing in Chinese population: a multicenter randomized, controlled trial [J]. Medicine (Baltimore), 2015, 94(4): e472. doi: 10.1097/MD.0000000000000472
计量
- 文章访问数: 363
- HTML全文浏览量: 150
- PDF下载量: 2
- 被引次数: 0